BIG SURPRISE TODAY. AIM HIGH TRIAL stopped early because of ischemic strokes in the patients on high dose extended release niacin.
Hopefully in the Orlando NLA meeting we will have the full evaluation of the data.
Were the strokes in metabolic patients?
Was the dose of Niacin 2,000 mg which may have made the insulin resistance worse in metabolic patients.
I use endur-acin 1,000/d with crestor 5 mg. I will continue this low dose at this time.
Keywords: niacin
